Extensive analytics and characterization are vital to ensure patient safety and drug substance efficacy for groundbreaking biologics. As compared to small molecules, biotherapeutic analytics require additional analysis to appropriately address molecule complexity.
Artificial Intelligence (AI) solutions are being implemented faster than ever, but this implementation needs to be intuitive and customer-centric to be effective. As a global CDMO with a legacy built on analytics, we are well-positioned to lead the way in digitally-transformative analytics to better serve our clients across the world.
From the inception of KBI Biopharma, analytics has been the cornerstone of our operations. We have leveraged advanced analytical techniques and methodologies to drive precision, efficiency, and innovation in our services. Not only is our commitment to analytics a rich part of our history, it’s also a driving force behind our present and future endeavors.
Our innovative approach to particle characterization is a testament to our dedication to analytical excellence. We have enhanced our ability to analyze and interpret complex datasets by employing machine learning algorithms, leading to more accurate and reliable results. This technological advancement streamlines our processes and ensures we remain at the cutting edge of analytical capabilities.
Analytics is a decision driver across every phase of a project cycle. At KBI, our deep expertise in analytics covers every project stage, from structure prediction and analysis to cell line development to commercial manufacturing - across non-cGMP and cGMP activities.
We employ a phase-specific interdisciplinary lifecycle approach to analytics. Combining cutting-edge technology, close collaboration, and keen insight, we create lasting solutions to analytical challenges that take your project from early-stage samples to highly purified drug substances.
Analytics are necessary for making informed decisions. Oftentimes, this comes with paperwork overload to meet policy requirements and the standard RFQ process alone can take months.
Our goal is to help you get your innovative biologics to patients, faster. Our new Analytics Portal converts this lengthy process into a fast and easy self-serve process for quote requests, order forms, sample submission, and real-time tracking and monitoring.
In our continuous pursuit of excellence and innovation, we are excited to announce the launch of our Analytical Portal and Online Ordering Form. This digital platform is a significant milestone in our digital transformation journey, reflecting our commitment to providing best-in-class client experiences and streamlined operations.
Key functionalities of the portal include:
Launching the Analytics Portal enhances our current capabilities and lays a solid foundation for future digital expansions in data access, visualization, search, modeling, and predictive analytics.
Do you have an Analytical Project? Request a Quote Now >>
With these and other ongoing initiatives, we are not only embracing the future but actively creating it. Our commitment to digital innovation is strong, and we are dedicated to exploring new frontiers in technology and analytics to ensure that KBI Biopharma and our customers are leading the way.
KBI Biopharma is more than just a CDMO; we are an innovation partner committed to advancing the industry and delivering unparalleled value to our clients. Discover the KBI difference today - get in touch with our team!